STOCKHOLDERS' EQUITY - Schedule of Equity-Classified Warrants (Details) - $ / shares	3 Months Ended									9 Months Ended				12 Months Ended
	Sep. 30, 2025		Jun. 30, 2025	Mar. 31, 2025		Sep. 30, 2024		Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2025		Sep. 30, 2024		Dec. 31, 2024		Dec. 31, 2023
Schedule of Equity-Classified Warrants [Line Items]
Weighted Average Remaining Contractual Life (Years), Expired
Warrants [Member]
Schedule of Equity-Classified Warrants [Line Items]
Number of Warrants, Total outstanding, Beginning	2,127,070		2,127,070	1,765,070	[1]	176,969		185,295	52,737	1,765,070	[1]	52,737		52,737
Weighted Average Exercise Price, Total outstanding, Beginning	$ 15.85		$ 15.85	$ 17.59	[1]	$ 128.09		$ 122.36	$ 369.98	$ 17.59	[1]	$ 369.98		$ 369.98
Weighted Average Remaining Contractual Life (Years), Total outstanding, Beginning														3 years 3 months 3 days	[1]	4 years 5 months 19 days
Number of Warrants, Granted	6,338,788	[2]		747,200		1,782,612			140,884
Weighted Average Exercise Price, Granted	$ 1.65	[2]		$ 3.56		$ 4.7			$ 22.48
Weighted Average Remaining Contractual Life (Years), Granted	3 years 3 months 21 days	[2]		2 years					5 years
Number of Warrants, Exercised	878,264			(385,200)				(8,326)	(8,326)
Weighted Average Exercise Price, Exercised	$ 0.001			$ 0.01				$ 0.6	$ 0.6
Weighted Average Remaining Contractual Life (Years), Exercised	Indefinite			Indefinite				Indefinite	Indefinite
Number of Warrants, Forfeited
Weighted Average Exercise Price, Forfeited
Weighted Average Remaining Contractual Life (Years), Forfeited
Number of Warrants, Expired
Weighted Average Exercise Price, Expired
Weighted Average Remaining Contractual Life (Years), Expired
Number of Warrants, Total outstanding, Ending	7,587,594		2,127,070	2,127,070		1,959,581	[3]	176,969	185,295	7,587,594		1,959,581	[3]	1,765,070	[1]	52,737
Weighted Average Exercise Price, Total outstanding, Ending	$ 5.82		$ 15.85	$ 15.85		$ 15.84	[3]	$ 128.09	$ 122.36	$ 5.82		$ 15.84	[3]	$ 17.59	[1]	$ 369.98
Weighted Average Remaining Contractual Life (Years), Total outstanding, Ending	2 years 9 months 25 days		2 years 1 month 6 days	2 years 7 months 6 days		4 years 1 month 28 days	[3]	4 years 4 months 28 days	4 years 8 months 1 day
Number of Warrants, Total exercisable	7,587,594					756,680	[4]			7,587,594		756,680	[4]
Weighted Average Exercise Price,Total exercisable	$ 5.82					$ 29.96	[4]			$ 5.82		$ 29.96	[4]
Weighted Average Remaining Contractual Life (Years),Total exercisable	2 years 9 months 25 days											4 years 1 month 28 days	[4]

[1] Weighted average remaining contractual life at December 31, 2024 excludes 385,200 Pre-Funded Warrants issued September 2024 that do not have a contractual expiration date, for which 0 warrants remain outstanding and exercisable at March 31, 2025, June 30, 2025 and September 30, 2025.

[2] Weighted average remaining contractual life excludes 878,264 Pre-Funded Warrants issued July 2025 that do not have a contractual expiration date, for which 0 warrants remain outstanding and exercisable at September 30, 2025.

[3] Weighted average remaining contractual life calculations exclude (i) 579,711 Pre-Funded Warrants issued September 2024 that do not have a contractual expiration date, (ii) 43,479 September 2024 Agent Warrants and 579,711 Series A Warrants issued September 2024 that expire five years from the Stockholder Approval Date, defined above, and (iii) 579,711 Series B Warrants issued September 2024 that expire eighteen months from the Stockholder Approval Date, which had not yet occurred as of September 30, 2024.

[4] Weighted average remaining contractual life calculation excludes 579,711 exercisable Pre-Funded Warrants issued September 2024 that do not have a contractual expiration date.